VLP Vaccine
Research Achievements
Quadrivalent vaccine for human papilloma virus prevention
Development and efficacy
verification of four antigens
for human papilloma vaccine
(HPV)
-
After completion of development, review of entry into the public vaccine market
(MOU with UBiologics) - L/O in progress
Optipharm Strategy
Entry into overseas public
vaccine markets
